Ohmyhome braces for Nasdaq bid-price deficiency; 180-day cure window ahead
Regulatory-style listing-deficiency news can pressure small-cap shares due to liquidity risk and uncertainty; potential reverse split adds dilution risk.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Regulatory-style listing-deficiency news can pressure small-cap shares due to liquidity risk and uncertainty; potential reverse split adds dilution risk.
What happened, with direct paths to the underlying reporting
Ohmyhome disclosed Nasdaq notified it of a bid-price deficiency after closing prices under $1 from May 28 through July 10, 2026. The company has 180 days to regain compliance, by January 11, 2027, by achieving at least $1 for 10 consecutive trading days. If not, a second extension and a potential reverse split could be considered; liquidity risk may persist.
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.